Relationship between body mass index, liver enzymes and high-sensitivity C-reactive protein in type 2 diabetes mellitus patients
DOI:
https://doi.org/10.18203/2320-6012.ijrms20240530Keywords:
Glycosylated haemoglobin, ALP, ALT, AST, hsCRPAbstract
Background: Obesity is a frequent co-morbid condition associated with excessive increase in weight. It is one of the most important modifiable risk factors in the pathogenesis of type 2 diabetes mellitus (T2DM). Obesity may be associated with liver disease and the progression of hepatic dysfunction. Also, highly sensitive C-reactive protein (hsCRP), which is elevated in inflammatory situations, can be produced by monocyte-derived macrophages in adipose tissue may also disrupt liver functions.
Methods: A case control study with 50 patients of T2DM and 50 age and sex matched individuals were taken to serve as controls.
Results: The body mass index (BMI) and waist circumference were increased in T2DM patients as compared to controls. However, the variations in liver enzymes alanine aminotransferase (ALT), aspartate aminotransferase (AST), and serum alkaline phosphatase (ALP) and hsCRP were increased in individuals of normal BMI as compared with individuals of overweight BMI.
Conclusions: Individuals with normal Body mass index had an increased risk of developing T2DM along with progression of hepatic dysfunction. No associations were observed between chronic low-grade inflammation and BMI and with pathogenesis of obesity-related insulin resistance.
References
Iyer A, Fairlie DP, Prins JB, Hammock BD, Brown L. Inflammatory lipid mediators in adipocyte function and obesity. Nat Rev Endocrinol. 2010;6:71-82.
Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of us adults. N Engl J Med. 2003;348:1625-38.
Ramachandran A, Snehalatha C, Dharmaraj D, Vishwanathan M. Prevalence of glucose intolerance in Asian Indians: Urban-Rural Difference and significance of upper body adiposity. Diabetes Care. 1992;15:1348-55.
Zhao Q, Laukkanen JA, Li Q, Li G. Body mass index is associated with type 2 diabetes mellitus in Chinese elderly. Clin Interventions Aging. 2017;12:745-52.
Hsu WC, Araneta MR, Kanaya AM, Chiang JL, Fujimoto W. BMI cut points to identify at-risk Asian Americans for type 2 diabetes screening. Diabetes Care. 2015;38(1):150-8.
Henriksson J. Influence of exercise on insulin sensitivity. J Cardiovasc Risk. 1995;2:303-9.
Janghorbain M, Hedley AJ, Jones RB. Is the association between glucose levels and “all causes” and cardiovascular mortality risk, dependent on body mass index? Met J IR I. 1991;6:205-12.
Phillips LK, Prins JB. The link between abdominal obesity and the metabolic syndrome. Curr Hypertens Rep. 2008;10(2):156-64.
Bakari AG, Onygemelukwe GC, Sani BG, Aliyu IS, Hassan SS, Aliyu TM. Relationship between random blood sugar and body mass index in an African population. Int J Diabetes Metab. 2006;14:144-5.
Pischon T, Nothlings U, Boeing H. Obesity and cancer. Proc Nutr Soc. 2008;67(2):128-45.
Després JP, Moorjani S, Lupien PJ, Tremblay A, Nadeau A, Bouchard C. Regional distribution of body fat, plasma lipoproteins, and cardiovascular disease. Arteriosclerosis. 1990;10(4):497-511.
Deurenberg P, Yap M, van Staveren WA. Body mass index and percent body fat: a meta analysis among different ethnic groups. Int J Obes Relat Metab Disord. 1998;22(12):1164-71.
Trinder P. Enzymatic determination of glucose in blood serum. Ann Clin Biochem. 1969;6:24.
Jeppsson JO, Kobold U, Barr J, Finke A. Approved IFCC reference method for the measurement of HbA1c in human blood Clin Chem Lab Med. 2002;40:78-89.
Thomas L. Alanine aminotransferase (ALT). In: Thomas L, editor. Clinical Laboratory Diagnostics. 1st Edition. 1998;55-65.
Thomas L. Aspartate aminotransferase (AST). In: Thomas L, editor. Clinical Laboratory Diagnostics. 1st Edition. 1998;55-65.
Tietz NW, Rinker AD, Shaw LM. IFCC methods for the measurement of catalytic concentration of enzymes Part 5. IFCC method for alkaline phosphatase (orthophosphoric-monoester phosphohydrolase, alkaline optimum, EC 3.1.3.1). J Clin Chem Clin Biochem. 1983;21(11):731-48.
Pulki K. Inflammatory Biomarkers in Asian Indian Women with Metabolic Syndrome. Sacand J Clin Lab Invest. 1986;46:606-7.
Janssen I, Bacon E. Effect of current and midlife obesity status on mortality risk in the elderly. Obesity (Silver Spring). 2008;16(11):2504-9.
World Health Organisation: Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser. 2000;894:1-253.
Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee. World Health Organ Tech Rep Ser. 1995;854:1-452.
Schulze MB, Heidemann C, Schienkiewitz A, Bergmann MM, Hoffmann K, Boeing H. Comparison of anthropometric characteristics in predicting the incidence of type 2 diabetes in the EPIC-Potsdam study. Diabetes Care. 2006;29(8):1921-3.
Montague CT, O' Rahilly S. The perils of portliness: causes and consequences of visceral adiposity. Diabetes. 2000;49(6):883-8.
Tomić M, Tamara P, Pavlic-Renar I, Metelko Ž. Obesity-risk factor for microvascuar and neuropatic complication in diabetes? Diabetologia Croatica. 2003;32(3):73-7.
Babikr WG, Alshahrani AS, Hamid HG, Abdelraheem AH, Shalayel MH. The correlation of HbA1c with body mass index and HDL-cholesterol in type 2 diabetic patients. Biomed Res. 2016;27(4):1280-3.
Khan AR, Awan FR, Najam SS. Elevated serum level of human alkaline phosphatase in obesity. J Pak Med Assoc. 2015;65:11.
